Effectiveness of combined bexarotene and excimer laser treatment for folliculotropic mycosis fungoides

Furukawa, Fumina; Makino, Teruhiko; Torai, Ryotaro; Mori, Shuichi; Terada, Yoshiyuki; Seki, Taiki; Shimizu, Tadamichi

doi:10.1684/ejd.2021.4085

Cited by 4 publications

(5 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2 The XTRAC velocity7 (STRATA Skin Sciences, Inc.) delivers coherent, monochromatic radiation and emits a high-intensity laser beam (83 000 W/cm 2 ) by pulsed oscillation. 3 We herein report two patients with generalized GA treated successfully with excimer laser therapy.…”

Section: Two Cases Of Generalized Granuloma Annulare Successfully Tre...mentioning

confidence: 95%

Two cases of generalized granuloma annulare successfully treated with an excimer laser

Mizawa

Makino

Oshima

et al. 2022

The Journal of Dermatology

Self Cite

View full text Add to dashboard Cite

Section: Two Cases Of Generalized Granuloma Annulare Successfully Tre...mentioning

confidence: 95%

Two cases of generalized granuloma annulare successfully treated with an excimer laser

Mizawa

Makino

Oshima

et al. 2022

The Journal of Dermatology

Self Cite

View full text Add to dashboard Cite

“…There have been few reports of this type in Japan, but it is more common in middle-aged and older patients with severe disease. 16 Since it appears after systemic symptoms, it may be a side effect of intravenous immunoglobulin (IVIG), ischemia of arteries, or disseminated intravascular coagulation syndrome. Findings of vasculitis have been reported.…”

Section: Purpuramentioning

confidence: 99%

Cutaneous manifestations of COVID‐19 and COVID‐19 vaccination

Nakashima

Kato

Otsuka

2023

The Journal of Dermatology

View full text Add to dashboard Cite

In December 2019, a new infectious pathogen named severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) was identified in Wuhan, China. Transmitted through respiratory droplets, SARS‐CoV‐2 is the causative pathogen of coronavirus disease 2019 (COVID‐19). Although this new COVID‐19 infection is known to cause primarily interstitial pneumonia and respiratory failure, it is often associated with cutaneous manifestations as well. These manifestations with COVID‐19 can be classified into seven categories: (i) chilblain‐like skin eruption (e.g., COVID toes), (ii) urticaria‐like skin eruption, (iii) maculopapular lesions, (iv) vesicular eruptions, (v) purpura, (vi) livedo reticularis and necrotic lesions, (vii) urticarial vasculitis, and others such as alopecia and herpes zoster. The pathogenesis of skin eruptions can be broadly divided into vasculitic and inflammatory skin eruptions. Various cutaneous adverse reactions have also been observed after COVID‐19 mRNA vaccination. The major cutaneous adverse reactions are type I hypersensitivity (urticaria and anaphylaxis) and type IV hypersensitivity (COVID arm and erythema multiform). Autoimmune‐mediated reactions including bullous pemphigus, vasculitis, vitiligo, and alopecia areata have also been reported. Several cases with chilblain‐like lesions and herpes zoster after COVID‐19 mRNA vaccination have been published. Various skin diseases associated with COVID‐19 and COVID‐19 vaccination have been reported, and the mechanism has been partly elucidated. In the process, for example, some papers have reported that it is not related to COVID‐19 infection, although it was initially called COVID‐toe and considered a COVID‐19‐associated cutaneous eruption. In fact, some COVID‐19‐associated skin reactions are indistinguishable from drug eruptions. In the future, the mechanisms of COVID‐19‐ or COVID‐19 vaccine‐associated skin reactions need to be elucidated and verification of causal relationships is required.

show abstract

“…LETTER TO THE EDITOR velocity7 delivers coherent, monochromatic radiation through a hand-held device with a 20 mm × 20 mm square spot size, and emits a high-intensity laser beam (83 000 W/cm 2 ) by pulsed oscillation. 3 This may lead to the disappearance of granuloma via a decrease of immunoreactivity associated with granuloma formation, even in the relatively deep region of the dermis. Furthermore, targeted phototherapy by excimer laser allows the exposure of healthy skin to UV radiation to be avoided in comparison to PUVA or NBUVB therapies.…”

Section: E237mentioning

confidence: 99%

“…Furthermore, targeted phototherapy by excimer laser allows the exposure of healthy skin to UV radiation to be avoided in comparison to PUVA or NBUVB therapies. 3 Accordingly, excimer laser treatment may be a useful therapeutic option, especially for localized cutaneous lesions of sarcoidosis.…”

Section: E237mentioning

confidence: 99%